Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Via Analysis of Immunoinflammation-related Protein Complexes in Blood
Overview
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 300
- Locations
- 1
- Primary Endpoint
- Immune Inflammation-Related Protein Pomplexes
Overview
Brief Summary
The relationship between immune inflammation-related protein complexes inblood and recurrence or metastasis of ovarian cancer will be studied
Detailed Description
100 cases in normal ovarian control group, 100 cases in benign ovarian disease group and 100 cases in malignant ovarian epithelial carcinoma group will be studied. Change regularity of ovarian cancer specific immune inflammation-related protein complexes in blood will be studied. The relationship between disease-specific protein complexes and pathological state of patients will be analyzed.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 20 Years to 70 Years (Adult, Older Adult)
- Sex
- Female
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Normal ovary control
- •Ovarian benign disease
- •Ovarian malignant epithelial carcinoma
Exclusion Criteria
- •Age above 70
- •Suffering from other malignant tumors
- •Non-compliant patient
Outcomes
Primary Outcomes
Immune Inflammation-Related Protein Pomplexes
Time Frame: 2 years
The change of immune inflammation-related protein complexes
Secondary Outcomes
No secondary outcomes reported